Marfan syndrome

Changed by Daniel J Bell, 6 Jul 2019

Updates to Article Attributes

Body was changed:

Marfan syndrome is a multisystem connective tissue disease caused by a defect in the protein fibrillin 1, encoded for by the FBN1 gene. Cardiovascular involvement with aortic root dilatation and dissection is the most feared complication of the disease.

Epidemiology

The estimated prevalence is around 2-6 per 100,000 2,5. There is no recognised gender or racial predilection.

Clinical presentation

Patients with Marfan syndrome may have the following symptoms and signs on history and examination:

Patients may present with complications of the disease such as, aortic dissection and pneumothorax.

Diagnostic criteria

TheGhent nosology was established in 1995 for the clinical diagnosis of the disease 7.

Pathology

Genetics

The condition is thought to resultresults from an inherited or de novoa mutation in the fibrillin 1 (FBN1) gene located on chromosome 15q21.1 which is responsible for cross-linking collagen. In the majority of cases it is inherited in an autosomal dominant fashion, although in up to one-third of cases the mutation is de novo. The disease has high genetic penetrance but with variable phenotypic expression even amongst affected family members.

Studies show a regulatory relationship between extracellular microfibrils and TGFβ signalling, so an abnormality in either can cause a Marfanoid phenotype 9.

Microscopic appearance

Microscopically the arterial walls may show cystic medial necrosis 10.

Radiographic features

There are no specific radiographic features of Marfan syndrome but the following signs and complications of the disease may be seen in each system on a range of modalities:

Skeletal
Cardiovascular
Pulmonary

Treatment and prognosis

Beta blockers are shown to reduce the rate of aortic root dilatation. In patients who can not take beta-blockers, calcium-channel blockers are used. More recently, investigators found that angiotensin receptor blockers which are also TGFβ antagonists significantly reduce cardiovascular and other somatic features 9. Cardiovascular complications are the most frequent cause of death 2.

Some of the more newer treatment options include.

History and etymology

First described in 1896 by Antoine Bernard-Jean Marfan, French paediatrician (1858-1942).

Differential diagnosis

Consider

  • -<p><strong>Marfan syndrome</strong> is a multisystem <a href="/articles/hereditary-connective-tissue-disease">connective tissue disease</a> caused by a defect in the protein fibrillin 1, encoded for by the FBN1 gene. Cardiovascular involvement with aortic root dilatation and <a href="/articles/aortic-dissection">dissection</a> is the most feared complication of the disease.</p><h4>Epidemiology</h4><p>The estimated prevalence is around 2-6 per 100,000 <sup>2,5</sup>. There is no recognised gender or racial predilection.</p><ul></ul><h4>Clinical presentation</h4><p>Patients with Marfan syndrome may have the following symptoms and signs on history and examination:</p><ul>
  • +<p><strong>Marfan syndrome</strong> is a multisystem <a href="/articles/hereditary-connective-tissue-disease">connective tissue disease</a> caused by a defect in the protein fibrillin 1, encoded for by the <em>FBN1</em> gene. Cardiovascular involvement with aortic root dilatation and <a href="/articles/aortic-dissection">dissection</a> is the most feared complication of the disease.</p><h4>Epidemiology</h4><p>The estimated prevalence is around 2-6 per 100,000 <sup>2,5</sup>. There is no recognised gender or racial predilection.</p><ul></ul><h4>Clinical presentation</h4><p>Patients with Marfan syndrome may have the following symptoms and signs:</p><ul>
  • -<li>long arm-span (often exceeding the height of the patient)</li>
  • +<li>long arm span (often exceeding the height of the patient)</li>
  • -<li>flexion deformity of the 5<sup>th</sup> finger</li>
  • +<li>flexion deformity of the little finger</li>
  • -<li>chest wall deformities (present in up to 2/3<sup>rds</sup> of cases <sup>2</sup>)<ul>
  • +<li>chest wall deformities (present in up to ⅔ of cases <sup>2</sup>)<ul>
  • -<li>myopia</li>
  • +<li><a href="/articles/myopia">myopia</a></li>
  • -<a href="/articles/aortic-valve-regurgitation">aortic regurgitation</a> or <a href="/articles/mitral-valve-regurgitation">mitral regurgitation</a> on auscultation</li></ul>
  • +<a href="/articles/aortic-valve-regurgitation">aortic regurgitation</a> or <a href="/articles/mitral-valve-regurgitation">mitral regurgitation</a>
  • +</li></ul>
  • -</ul><p>Patients may present with complications of the disease such as, <a href="/articles/aortic-dissection">aortic dissection</a> and <a href="/articles/pneumothorax">pneumothorax</a>.</p><h5>Diagnostic criteria</h5><p>The<strong> </strong>Ghent nosology was established in 1995 for the clinical diagnosis of the disease <sup>7</sup>.</p><h4>Pathology</h4><p>The condition is thought to result from an inherited or de novo mutation in the fibrillin 1 (<em>FBN1</em>) gene located on chromosome 15q21.1 which is responsible for cross-linking collagen. In the majority of cases it is inherited in an autosomal dominant fashion, although in up to one-third of cases the mutation is de novo. The disease has high genetic penetrance but with variable phenotypic expression even amongst affected family members.</p><p>Studies show a regulatory relationship between extracellular microfibrils and TGFβ signalling, so an abnormality in either can cause a Marfanoid phenotype <sup>9</sup>.</p><h5>Microscopic appearance</h5><p>Microscopically the arterial walls may show cystic medial necrosis <sup>10</sup>.</p><h4>Radiographic features</h4><p>There are no specific radiographic features of Marfan syndrome but the following signs and complications of the disease may be seen in each system on a range of modalities:</p><h5>Skeletal</h5><ul>
  • +</ul><p>Patients may present with complications of the disease such as, <a href="/articles/aortic-dissection">aortic dissection</a> and <a href="/articles/pneumothorax">pneumothorax</a>.</p><h5>Diagnostic criteria</h5><p>The<strong> </strong>Ghent nosology was established in 1995 for the clinical diagnosis of the disease <sup>7</sup>.</p><h4>Pathology</h4><h5>Genetics</h5><p>The condition results from a mutation in the fibrillin 1 (<em>FBN1</em>) gene located on chromosome 15q21.1 which is responsible for cross-linking collagen. In the majority of cases it is inherited in an autosomal dominant fashion, although in up to one-third of cases the mutation is de novo. The disease has high genetic penetrance but with variable phenotypic expression even amongst affected family members.</p><p>Studies show a regulatory relationship between extracellular microfibrils and TGFβ signalling, so an abnormality in either can cause a Marfanoid phenotype <sup>9</sup>.</p><h5>Microscopic appearance</h5><p>Microscopically the arterial walls may show cystic medial necrosis <sup>10</sup>.</p><h4>Radiographic features</h4><p>There are no specific radiographic features of Marfan syndrome but the following signs and complications of the disease may be seen in each system on a range of modalities:</p><h5>Skeletal</h5><ul>
  • -<a title="tibial subluxation" href="/articles/tibial-subluxation">tibial subluxation</a> <sup>5</sup>
  • +<a href="/articles/tibial-subluxation">tibial subluxation</a> <sup>5</sup>
  • -<li>flexion deformity of the 5<sup>th</sup> finger</li>
  • +<li>flexion deformity of the little finger(s)</li>
  • -<li>aortic root diameter &gt; 55 mm</li>
  • +<li>aortic root diameter &gt;55 mm</li>
  • -<a href="/articles/personalised-external-aortic-root-support-pears">personalised external aortic root support</a> (PEARS) procedure</li></ul><h4>History and etymology</h4><p>First described in 1896 by <strong>Antoine Bernard-Jean Marfan</strong>, French paediatrician (1858-1942).</p><h4>Differential diagnosis</h4><p>Consider</p><ul>
  • -<li>patients with <a href="/articles/loeys-dietz-syndrome-2">Loeys-Dietz syndrome </a>have similar features to Marfan syndrome</li>
  • -<li>patients with <a href="/articles/homocystinuria">homocystinuria</a> may resemble those with Marfan syndrome in some aspects<sup> 8</sup>;<sup> </sup>ectopia lentis, however, is downward as opposed to Marfan and intellectual disability is also a common feature</li>
  • -<li>patients with <a href="/articles/multiple-endocrine-neoplasia-type-iib">multiple endocrine neoplasia type IIb</a> may have a Marfan syndrome like body habitus </li>
  • -<li>patients with <a href="/articles/beals-syndrome-2">Beals syndrome</a> have some features of Marfan syndrome</li>
  • +<a href="/articles/personalised-external-aortic-root-support-pears">personalised external aortic root support (PEARS)</a> procedure</li></ul><h4>History and etymology</h4><p>First described in 1896 by <strong>Antoine Bernard-Jean Marfan</strong>, French paediatrician (1858-1942).</p><h4>Differential diagnosis</h4><ul>
  • +<li>
  • +<a href="/articles/congenital-contractural-arachnodactyly-1">congenital contractural arachnodactyly​</a>: has significant phenotypic overlap with Marfan syndrome, but is now considered a discrete entity, due to distinct genetics <sup>11</sup>
  • +</li>
  • +<li>
  • +<a href="/articles/loeys-dietz-syndrome-2">Loeys-Dietz syndrome</a>: similar features to Marfan syndrome</li>
  • +<li>
  • +<a href="/articles/homocystinuria">homocystinuria</a>: may resemble those with Marfan syndrome in some aspects<sup> 8</sup>;<sup> </sup><a title="Ectopia lentis" href="/articles/ectopia-lentis">ectopia lentis</a>, however, is downward as opposed to Marfan and intellectual disability is also a common feature</li>
  • +<li>
  • +<a href="/articles/multiple-endocrine-neoplasia-type-iib">multiple endocrine neoplasia type IIb</a> may have a Marfan syndrome like body habitus</li>

References changed:

  • 11. Tunçbilek E, Alanay Y. Congenital contractural arachnodactyly (Beals syndrome). (2006) Orphanet journal of rare diseases. 1: 20. <a href="https://doi.org/10.1186/1750-1172-1-20">doi:10.1186/1750-1172-1-20</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/16740166">Pubmed</a> <span class="ref_v4"></span>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.